Your browser doesn't support javascript.
loading
Translation of in vitro cannabinoid 1 receptor agonist activity to in vivo pharmacodynamic endpoints.
Jenkinson, Stephen; Goody, Susan M G; Bassyouni, Asser; Jones, Rhys; Otto-Bruc, Annie; Duquennoy, Stephanie; DaSilva, Jamie K; Butler, Paul; Mead, Andy.
Afiliação
  • Jenkinson S; Worldwide Research and Development, Pfizer Inc., La Jolla, CA 92121, USA. Electronic address: stephen.jenkinson@pfizer.com.
  • Goody SMG; Worldwide Research and Development, Pfizer Inc., Groton, CT 06340, USA.
  • Bassyouni A; Worldwide Research and Development, Pfizer Inc., La Jolla, CA 92121, USA.
  • Jones R; Worldwide Research and Development, Pfizer Inc., La Jolla, CA 92121, USA.
  • Otto-Bruc A; Eurofins CEREP SA, Celle-Levescault, France.
  • Duquennoy S; Eurofins CEREP SA, Celle-Levescault, France.
  • DaSilva JK; Worldwide Research and Development, Pfizer Inc., Groton, CT 06340, USA.
  • Butler P; Worldwide Research and Development, Pfizer Inc., La Jolla, CA 92121, USA.
  • Mead A; Worldwide Research and Development, Pfizer Inc., Groton, CT 06340, USA.
J Pharmacol Toxicol Methods ; 104: 106899, 2020.
Article em En | MEDLINE | ID: mdl-32702414

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: AMP Cíclico / Receptor CB1 de Canabinoide / Agonistas de Receptores de Canabinoides / Beta-Arrestinas Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: J Pharmacol Toxicol Methods Assunto da revista: FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: AMP Cíclico / Receptor CB1 de Canabinoide / Agonistas de Receptores de Canabinoides / Beta-Arrestinas Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: J Pharmacol Toxicol Methods Assunto da revista: FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2020 Tipo de documento: Article